FDA approves postpartum depression pill

Name: FDA approves postpartum depression pill
Uploaded: 2023-08-08T22:43:08Z
Duration: 2 min 18 s
Description: The first-ever drug created specifically to combat postpartum depression was approved by the U.S. Food and Drug Administration (FDA) on Tuesday. Zulresso, created by Sage Therapeutics, is an IV drug administered "as a continuous infusion" over the course of 60 hours, or two and a half days, the agency announced in a news release.

The first-ever drug created specifically to combat postpartum depression was approved by the U.S. Food and Drug Administration (FDA) on Tuesday. Zulresso, created by Sage Therapeutics, is an IV drug administered "as a continuous infusion" over the course of 60 hours, or two and a half days, the agency announced in a news release.

Posted August 8, 2023 6:43pm EDT